For all intents and purposes, CF33 is safe and it works as it has been seen to kill cancer. YF is waiting for biopsies and independent verification to confirm what he "knows", with a snippet of such in the latest poster presentation. LC doesn't want to take the limelight from CF33's inventor, YF, and is waiting for him to publish. LC emphatically stated fast track was an option. IMU have a lab set up to produce CF33. Oncologists are hearing of CF33 and patients are allegedly lining up. The FDA can review and decide on a fast track / break through therapy application in 60 days. The Co is waiting for a "big" announcement prior to Nasdaq listing. LC has stated that they don't want to go through Phase 3, but what if they don't have to? If the stars align, Ben's $1 prediction may be on the low side.
Not financial advice and all IMO but I reckon there's a lot to look forward to as the year progresses.
IMU Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)